TMQ showed superior therapeutic effects to TM in non-small cell lung cancer, including an increased splenic index, IFN-γ, ROS, and MDA levels, and decreased TNF-α and IL-6 levels. This evidence concerns the gene IFNG and non-small cell lung carcinoma.